SCHEMBL5587262

SCHEMBL5587262

CCCCC(C)C1(c2cccc(O)c2O)CCCCC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 5/20 0.37
SLC6A3 Q01959 5/20 0.37
SLC6A2 P23975 1/20 0.36
IAPP P10997 2/20 0.33
CETP P11597 4/20 0.33
OPRM1 P35372 2/20 0.33
OPRD1 P41143 2/20 0.33
CNR1 P21554 1/20 0.32
CNR2 P34972 1/20 0.32
CTSL P07711 1/20 0.31
CTSB P07858 1/20 0.31
CTSK P43235 1/20 0.31
AKT1 P31749 2/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
OPRK1 P41145 1/20 0.31
OPRL1 P41146 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590699 0.92 SLC6A3 (0.38) SLC6A4SLC6A3SLC6A2IAPPOPRM1
SCHEMBL5588250 0.85 SLC6A4 (0.36) SLC6A4SLC6A3SLC6A2IAPPCETP
SCHEMBL5590691 0.76 CNR2 (0.47) SLC6A4SLC6A3SLC6A2IAPPCETP
SCHEMBL28188868 0.75 HPGD (0.38) SLC6A4SLC6A3SLC6A2CETPOPRM1
SCHEMBL5587103 0.74 CNR2 (0.42) SLC6A4SLC6A3SLC6A2IAPPCETP
SCHEMBL27262560 0.74 SLC6A4 (0.46) SLC6A4SLC6A3SLC6A2OPRM1OPRD1
SCHEMBL5587327 0.71 SLC6A2 (0.37) SLC6A4SLC6A3SLC6A2IAPPCETP
SCHEMBL5586872 0.70 SLC6A2 (0.42) SLC6A4SLC6A3SLC6A2OPRM1OPRD1
SCHEMBL28187956 0.68 CNR2 (0.50) SLC6A4SLC6A3SLC6A2CETPCNR1
SCHEMBL5589660 0.68 HSD17B10 (0.41) OPRM1OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US disclosed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP disclosed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US disclosed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP disclosed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 SLC6A4 2459/4885SLC6A3 1564/4885SLC6A2 3185/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.